167 related articles for article (PubMed ID: 19448192)
1. Current therapeutic drugs for type 2 diabetes, still useful after 50 years?
Hall GM; Nicholson G
Anesth Analg; 2009 Jun; 108(6):1727-30. PubMed ID: 19448192
[No Abstract] [Full Text] [Related]
2. Landmarks in diabetes care: a historical perspective.
Suleyman F
Community Nurse; 1998 Jul; 4(6):13-6. PubMed ID: 9763975
[TBL] [Abstract][Full Text] [Related]
3. Type 2 Diabetes: Progress Made but Still a Long Road to Travel to Reduce Disease Burden.
Terra SG; Vincent J
Clin Pharmacol Ther; 2015 Aug; 98(2):108-11. PubMed ID: 26013760
[No Abstract] [Full Text] [Related]
4. Metformin: the unauthorized biography.
Dubois W
Diabetes Self Manag; 2013; 30(3):8-14. PubMed ID: 23951628
[No Abstract] [Full Text] [Related]
5. Do we need new drugs for the treatment of type 2 diabetes mellitus?
Vervoort G; Tack CJ
Neth J Med; 2007 May; 65(5):157-9. PubMed ID: 17519510
[No Abstract] [Full Text] [Related]
6. Metformin: 50 years old, fit as a fiddle, and indispensable for its pivotal role in type 2 diabetes management.
Halimi S
Diabetes Metab; 2006 Dec; 32(6):555-6. PubMed ID: 17296508
[No Abstract] [Full Text] [Related]
7. [Metformin in type 2 diabetes. An extensive observational study confirms the agent as first choice--so far].
Rydén M
Lakartidningen; 2011 Jan 26-Feb 1; 108(4):136. PubMed ID: 21365817
[No Abstract] [Full Text] [Related]
8. Metabonomic study of biochemical changes in the serum of type 2 diabetes mellitus patients after the treatment of metformin hydrochloride.
Huo T; Cai S; Lu X; Sha Y; Yu M; Li F
J Pharm Biomed Anal; 2009 May; 49(4):976-82. PubMed ID: 19249171
[TBL] [Abstract][Full Text] [Related]
9. Metformin discontinuation rate among patients with type-2 diabetes mellitus in Basrah, Iraq.
Mansour AA; Habib OS
Saudi Med J; 2007 Dec; 28(12):1919-21. PubMed ID: 18060234
[No Abstract] [Full Text] [Related]
10. Treatment with metformin is protective against limitations in instrumental activities of daily living in older subjects with type 2 diabetes mellitus.
Mazziotti G; Bossoni S; Orini S; Salimbeni P; Gazzaruso C; Solerte BS; Vescovi P; Romanelli G; Giustina A
J Am Geriatr Soc; 2009 Mar; 57(3):562-4. PubMed ID: 19278401
[No Abstract] [Full Text] [Related]
11. Islet enhancer vildagliptin: a powerful partner with metformin for the treatment of patients with type 2 diabetes.
Scherbaum WA
Diabetes Obes Metab; 2009 May; 11 Suppl 2():1-2. PubMed ID: 19385977
[No Abstract] [Full Text] [Related]
12. Type 2 diabetes.
Draznin MB
Adolesc Med State Art Rev; 2008 Dec; 19(3):498-506, x. PubMed ID: 19227388
[TBL] [Abstract][Full Text] [Related]
13. Choosing first-line therapy for management of type 2 diabetes.
Graber MA; Darby-Stewart A; Dachs R
Am Fam Physician; 2008 Jan; 77(1):16-7. PubMed ID: 18236820
[No Abstract] [Full Text] [Related]
14. Metformin in heart failure.
Inzucchi SE; Masoudi FA; McGuire DK
Diabetes Care; 2007 Dec; 30(12):e129. PubMed ID: 18042738
[No Abstract] [Full Text] [Related]
15. Follow-up of intensive glucose control in type 2 diabetes.
Petrie JR
N Engl J Med; 2009 Jan; 360(4):416-7; author reply 418. PubMed ID: 19172672
[No Abstract] [Full Text] [Related]
16. Follow-up of intensive glucose control in type 2 diabetes.
Mühlhauser I
N Engl J Med; 2009 Jan; 360(4):417; author reply 418. PubMed ID: 19172674
[No Abstract] [Full Text] [Related]
17. Getting an extension.
Diabetes Obes Metab; 2002 Mar; 4(2):139-40. PubMed ID: 11993444
[No Abstract] [Full Text] [Related]
18. Beans and diabetes: Phaseolus vulgaris preparations as antihyperglycemic agents.
Helmstädter A
J Med Food; 2010 Apr; 13(2):251-4. PubMed ID: 20132042
[TBL] [Abstract][Full Text] [Related]
19. New weapons to combat an ancient disease: treating diabetes.
Patlak M
FASEB J; 2002 Dec; 16(14):1853. PubMed ID: 12468446
[No Abstract] [Full Text] [Related]
20. Metformin: diamonds are forever.
Papanas N; Maltezos E; Mikhailidis DP
Expert Opin Pharmacother; 2009 Oct; 10(15):2395-7. PubMed ID: 19678795
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
